Cargando…
Overcoming Barriers to Preventing and Treating P. aeruginosa Infections Using AAV Vectored Immunoprophylaxis
Pseudomonas aeruginosa is a bacterial pathogen of global concern and is responsible for 10–15% of nosocomial infections worldwide. This opportunistic bacterial pathogen is known to cause serious complications in immunocompromised patients and is notably the leading cause of morbidity and mortality i...
Autores principales: | Lopes, Jordyn A., Rghei, Amira D., Thompson, Brad, Susta, Leonardo, Khursigara, Cezar M., Wootton, Sarah K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775905/ https://www.ncbi.nlm.nih.gov/pubmed/36551918 http://dx.doi.org/10.3390/biomedicines10123162 |
Ejemplares similares
-
AAV Vectored Immunoprophylaxis for Filovirus Infections
por: Rghei, Amira D., et al.
Publicado: (2020) -
Recent Advancements in AAV-Vectored Immunoprophylaxis in the Nonhuman Primate Model
por: Campbell, Elena S. B., et al.
Publicado: (2023) -
Safety and Tolerability of the Adeno-Associated Virus Vector, AAV6.2FF, Expressing a Monoclonal Antibody in Murine and Ovine Animal Models
por: Rghei, Amira D., et al.
Publicado: (2021) -
Vectored immunoprophylaxis: an emerging adjunct to traditional vaccination
por: Sanders, John W., et al.
Publicado: (2017) -
The Role of Pseudomonas aeruginosa Lipopolysaccharide in Bacterial Pathogenesis and Physiology
por: Huszczynski, Steven M., et al.
Publicado: (2019)